Medicare to limit coverage for Aduhelm, an Alzheimer's drug with questionable benefits that triggered a jump in premiums

WASHINGTON (AP) — Medicare to limit coverage for Aduhelm, an Alzheimer's drug with questionable benefits that triggered a jump in premiums.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting